Stomach drug may tame blood sugar swings in type 1 diabetes

NCT ID NCT06695962

Not yet recruiting Disease control Sponsor: University Hospital, Rouen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether domperidone, a drug that speeds up stomach emptying, can help people with type 1 diabetes keep their blood sugar in a healthy range. About 70 adults with type 1 diabetes who have slow stomach emptying but no digestive symptoms will take either domperidone or a placebo for 28 days. The main goal is to see if the drug increases the time their blood sugar stays within the target range, measured by a continuous glucose monitor.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELAYED GASTRIC EMPTYING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroparesis type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETIC

Contacts and locations

Locations

CH Dieppe

Dieppe, France
CHU Amiens

Amiens, France
CHU de CAEN

Caen, France
CHU de ROUEN

Rouen, France
Centre Hospitalier Intercommunal Elbeuf, Louviers, Val de Reuil

Elbeuf, France
GH Le Havre

Le Havre, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.